Page results
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
Testing for NHS staff, provided by the Francis Crick Institute and UCLH NHS Foundation Trust, detected COVID-19 infections that would have otherwise been missed.
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Short videos on managing cancer pain, cancer-related fatigue and improving sleep
-
Read more about the Halcyon linear accelerator, aimed at making cancer treatment faster, more comfortable, and more precise for patients.
-
Researchers at UCLH and Imperial College Healthcare NHS Trust are to trial a new weight loss treatment which involves reducing blood supply to part of the stomach.
-
At UCLH we run seasonal COVID-19 vaccination clinics from our Hospital Hub within UCH. Vaccinations are available to members of the eligible public as well as UCLH patients.
-
It’s a clean sweep for our nominees at this year’s RCN Nursing Awards. Congratulations to winners Jo Hargroves, Robert Vicente and Susie Lagrata!
-
A healthcare project aimed at homeless people and delivered by UCLH has been specially commended in this year’s London Homelessness Awards.
-
John McGrath is a newly appointed governor as a stakeholder member from North Central London Clinical Commissioning Group (CCG). He is a local GP and has lived and worked in Islington for the last decade in a number of different settings, including multiple GP surgeries as a salaried doctor, local A&E departments and urgent care.
File results
-
FOI/2023/0647 - Radiation Protection Supervisor
-
FOI/2023/0637 - Trust’s policy/eligibility for treatment at Eastman Dental Hospital
-
FOI/2023/0635 - Redundancy consultation
-
FOI/2023/0623 - BMA rate card rates
-
FOI/2023/0617 - Neonatal unit CCTV
-
FOI/2023/0615 - Wayfinding strategy
-
FOI/2023/0613 - Treatment for Melanoma
-
FOI/2023/0609 - Companies that currently have contracts at UCLH
-
FOI/2023/0604 - Patient flow system
-
FOI/2023/0569 - Treatment for Ruxolitinib